Skip to content

An observational study:Relaxin levels in patients with atrial fibrillation and its relationship with atrial fibrosis

An observational study:Relaxin levels in patients with atrial fibrillation and its relationship with atrial fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006130
Enrollment
Unknown
Registered
2014-10-30
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillaiton

Interventions

AF Group :Radiofrequency ablation or conservative treatment
Control Group:None

Sponsors

The first hospital affiliated of wenzhou medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients are diagnosed by electrocardiogram as atrial fibrillation; 2.Patients provide voluntarily his/her blood samples and cooperate with treatment and check; 3.Patients are willing to review and follow-up after atrial fibrillation with radiofrequency ablation for 5 to 7 months.

Exclusion criteria

Exclusion criteria: 1.Patients who eventually are diagnosed as other types of arrhythmias; 2.The acute heart failure patients need dialysis or rescue breathing machine; 3.Patients who are hemodynamic instability or myocardial infarction for killip 3-4 level need breathing machine or IABP support; 4.Patients who appear severe complications after ablation, such as injure the his bundle, II or III degree atrioventricular block and cardiac perforation; 5.Any situation that researchers consider the patient's condition will interfere is not be into the group.

Design outcomes

Primary

MeasureTime frame
Relaxin;Blood;

Countries

China

Contacts

Public ContactHao Zhou
wyzh66@126.com+86 13968801939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 3, 2026